l.trevino

TL2 · Genoa

Contributes reviews on supplier material. Based in Genoa.

Joined 3 January 2025 · last posted 3d

64 posts, newest first. Showing up to 150.

Documenting a supplier's response to a discrepancy Replied, post #48 · Sourcing › Vendor reports · 25 Jul 2026 · 32 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #118 · Evidence › Journal club · 19 Jul 2026 · 0 likes Adding a data point of agreement rather than a data point.
Programming during a large energy deficit Replied, post #38 · Nutrition & Training › Resistance training · 12 Jul 2026 · 15 likes The reason programming during a large energy is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one…
Revisiting: The best-written scientific paper you have read Replied, post #86 · Lounge › Off topic · 12 Jul 2026 · 0 likes Best-written scientific paper is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
How shortages have affected compounding permissions Replied, post #30 · Access › Shortages · 11 Jul 2026 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful. I…
What to bring: records that a clinician can actually use — a second dataset Replied, post #7 · Clinical › Prescriber conversations · 4 Jul 2026 · 2 likes Post #5 describes the usual case. This is about the unusual one. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #78 · Evidence › Journal club · 3 Jul 2026 · 11 likes Same experience here, different supplier, so it is at least not unique to one of them.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 6 likes I read post #6 twice before replying, because I had assumed the opposite. An observation about four-week escalation interval that I cannot explain and am posting…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #44 · Access › International · 29 Jun 2026 · 6 likes Agreed on all of that, and I have nothing to add to it.
Reading a home test result without over-claiming Replied, post #88 · Analytics › Home & field testing · 21 Jun 2026 · 10 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #92 · Practice › Reconstitution · 21 Jun 2026 · 24 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. That is what the…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #51 · Analytics › Home & field testing · 16 Jun 2026 · 27 likes Two people in this thread mean different things by Reflectance and photometric devices and are disagreeing about the definition while believing they are disagreeing…
Injecting into an area that has become firm: why not to Replied, post #53 · Practice › Administration · 11 Jun 2026 · 17 likes Post #50 is the version of this I will quote in future. One addition. Note the site alongside the dose. If a local reaction appears three weeks later you will want to…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #2 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 2 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
Coming back to: A structured critique template this community uses Replied, post #24 · Evidence › Study critique · 2 Jun 2026 · 19 likes The useful distinction on structured critique template is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
Revisiting: What pooling buys you and what it destroys Replied, post #25 · Evidence › Meta-analyses · 17 May 2026 · 2 likes Adding a small correction to the pooling buys summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #105 · Devices › Syringes & needles · 10 May 2026 · 5 likes I read post #103 twice before replying, because I had assumed the opposite. Reading the barrel at eye level matters more than any equipment choice. Parallax at a…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #2 · Clinical › Bloodwork · 5 May 2026 · 21 likes A note on how HbA1c lag gets discussed rather than on HbA1c lag itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #17 · Compounds › Oral incretins · 8 Apr 2026 · 4 likes The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the oral product, and the instruction exists because the…
Bioimpedance and hydration: why the number moves Replied, post #16 · Outcomes › Body composition · 10 Mar 2026 · 5 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month. Speaking for myself and not for anyone else who has…
Grapefruit: why this class is not the class that cares Replied, post #3 · Practice › Interactions · 1 Mar 2026 · 1 like For anyone finding this later: the short answer on grapefruit is that it depends on one thing, and the rest of the thread is people identifying which thing.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #109 · Practice › Interactions · 11 Feb 2026 · 8 likes On post #106 — agreed on the reasoning, with one qualification. Warfarin and altered intake is well covered in the tag pages, and the older discussions are better than…
When to stop reading forums, including this one Replied, post #82 · Wellbeing › Mental health · 28 Jan 2026 · 24 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Trifluoroacetate content and its consequences Replied, post #33 · Analytics › Impurities & related substances · 27 Jan 2026 · 3 likes Post #30 is right about the mechanism and I think understates the practical bit. Trifluoroacetate content is a question about a distribution, not about a value, and…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #56 · Start Here › How to Ask · 25 Jan 2026 · 23 likes Post #55 describes the usual case. This is about the unusual one. A question about somebody else's post should be a reply to that post, not a new topic. A question the…
What to include when your question involves a chromatogram Replied, post #53 · Start Here › How to Ask · 18 Jan 2026 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
Reading an interaction checker output critically Replied, post #81 · Practice › Interactions · 1 Jan 2026 · 8 likes Post #78 is right about the mechanism and I think understates the practical bit. Where the reading an interaction checker output discussion usually stalls is that…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #99 · Analytics › COA interpretation · 28 Dec 2025 · 1 like "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured.
Prescription requirements and telehealth models Replied, post #70 · Sourcing › Regulatory · 16 Dec 2025 · 15 likes Picking up post #69: that is the part I would want checked first. Agreed on prescription requirements and telehealth models, with one qualification that I think…
When to stop reading forums, including this one Replied, post #61 · Wellbeing › Mental health · 13 Dec 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #80 · Compounds › Oral incretins · 8 Dec 2025 · 10 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
Substitution between formats during a shortage Replied, post #85 · Access › Shortages · 30 Oct 2025 · 9 likes Nothing to add on the substance. Thank you for taking the question at face value.
Power cut for eleven hours: how I assessed it afterwards Replied, post #108 · Practice › Storage & stability · 23 Oct 2025 · 19 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Two people can read the same figure…
Reconciling a supplier certificate with an independent result Replied, post #5 · Sourcing › Vendor reports · 13 Oct 2025 · 0 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #80 · Analytics › HPLC & UHPLC · 23 Sep 2025 · 17 likes Adding the measurement that post #79 says would settle it. One more thing on Resolution and tailing factor that took me far too long to see: the two figures people…
Comparing my trajectory with the trial curves, carefully Replied, post #51 · Outcomes › Progress reports · 20 Sep 2025 · 0 likes Post #49 describes the usual case. This is about the unusual one. The best progress reports here read as records rather than as arguments, and that difference is…
Power cut for eleven hours: how I assessed it afterwards Replied, post #63 · Practice › Storage & stability · 19 Sep 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #21 · Compounds › Tirzepatide · 16 Sep 2025 · 27 likes Post #19 answers the question as asked. The question underneath it is different. An observation about dual agonism that I cannot explain and am posting anyway, on the…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #51 · Compounds › Secretagogues & GH axis · 10 Aug 2025 · 17 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Immortal time bias in a claims-database study Replied, post #9 · Evidence › Study critique · 29 Jul 2025 · 15 likes Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking. That is what I would do. It…
A ten-fold dose error caught before injection Replied, post #69 · Devices › Syringes & needles · 22 Jul 2025 · 17 likes Buying a box of the wrong barrel size is the most common regret described in this subcategory, and the reason is nearly always that the dose was decided after the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #24 · Access › Insurance & coverage · 24 Jun 2025 · 0 likes Where I part company with post #21, and it is a narrow parting. Prior authorisation criteria are usually published by the payer, and reading them before the appointment…
Half-life, steady state, and accumulation worked through Replied, post #90 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #9 · Evidence › Trials · 2 Jun 2025 · 3 likes Seconded. It reads as careful rather than confident, which is the right register.
Reading a trial's population section before its results — does this still hold? Replied, post #145 · Evidence › Trials · 25 May 2025 · 0 likes Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #38 · Clinical › Comorbidities · 22 May 2025 · 1 like Adding the measurement that post #35 says would settle it. Cardiovascular risk has a well-known answer and a correct answer, and the interesting work is establishing…
Triple agonism: additive, synergistic, or neither? Replied, post #45 · Compounds › Retatrutide · 12 May 2025 · 0 likes Triple agonism is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which…
Certificates issued by the seller versus by a laboratory Replied, post #20 · Analytics › COA interpretation · 27 Mar 2025 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. The distinction between release testing and characterisation is…
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #11 · Clinical › Bloodwork · 17 Mar 2025 · 27 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
Units, standards, and other things that quietly hold the world together Started this topic · Lounge › Off topic · 15 Mar 2025 · 34 likes Units, standards, and other things that quietly hold the world together — setting out what I have, and where I think it stops being reliable. I was wrong about units in…
What changed in 2026, by region Replied, post #96 · Access › International · 24 Jan 2025 · 24 likes Narrowing post #93, because the general version has more than one answer. Temperature-controlled material and long-haul travel is a practical problem with practical…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #36 · Compounds › Secretagogues & GH axis · 15 Jan 2025 · 4 likes No disagreement from me. Posting only so the question does not look ignored.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #142 · Practice › Dosing & titration · 5 Jan 2025 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
SURPASS-2 and the comparator dose question that will not go away Replied, post #81 · Compounds › Tirzepatide · 17 Dec 2024 · 0 likes The documentation on SURPASS-2 is better than this thread and I say that as someone who has posted in the thread.
Converting between mg/mL and units per dose, both directions Replied, post #128 · Practice › Reconstitution · 13 Dec 2024 · 15 likes Confirming post #126 from a second method, which matters more than confirming it from a second person. A 0.3 mL barrel has more space between graduations than a 1 mL…
Telehealth prescribing models in the US Replied, post #31 · Regional › North America · 8 Dec 2024 · 20 likes Following this. I have the same question and no better information than the first post.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #59 · Clinical › Prescriber conversations · 14 Nov 2024 · 17 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #63 · Analytics › Method validation · 31 Oct 2024 · 21 likes No notes. Posting so the count is not one.
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #12 · Analytics › Method validation · 30 Sep 2024 · 15 likes Everything in post #8 holds. The case it does not cover is the one I have. Nobody has said the unglamorous part of Relative retention time yet, so: most of the…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #49 · Compounds › Retatrutide · 20 Sep 2024 · 3 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
A rising related-substance total over six months: degradation or method drift? Replied, post #28 · Analytics › Impurities & related substances · 2 Sep 2024 · 25 likes Understood. Thank you for being specific about the limits of it.
When a red flag was a misunderstanding, and the retraction Replied, post #4 · Sourcing › Red flags · 18 Aug 2024 · 6 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. Worth reading the earlier posts in this…
Why I ask for the gradient before I discuss the number Replied, post #6 · Analytics › HPLC & UHPLC · 10 Jul 2024 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Spreadsheets: an appreciation Replied, post #7 · Lounge › Off topic · 5 Jun 2024 · 30 likes Offering a way to settle spreadsheets rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…